id | C00001710 |
---|---|
Name | Cryptolepine |
CAS RN | 480-26-2 |
Standard InChI | InChI=1S/C16H12N2/c1-18-15-9-5-2-6-11(15)10-14-16(18)12-7-3-4-8-13(12)17-14/h2-10H,1H3 |
Standard InChI (Main Layer) | InChI=1S/C16H12N2/c1-18-15-9-5-2-6-11(15)10-14-16(18)12-7-3-4-8-13(12)17-14/h2-10H,1H3 |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 2144 |
By standard InChI | CHEMBL119096 |
---|---|
By standard InChI Main Layer | CHEMBL119096 CHEMBL456244 |
By LinkDB | C09142 |
---|
By CAS RN | C024015 |
---|
class name | count |
---|---|
asterids | 2 |
family name | count |
---|---|
Apocynaceae | 2 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Cryptolepis sanguinolenta | 165212 | Apocynaceae | asterids | Viridiplantae |
Cryptolepis triangularis | 165212 | Apocynaceae | asterids | Viridiplantae |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C024015 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | cryptolepine results in increased expression of BAX mRNA |
increases expression
|
mRNA |
16120219
|
C024015 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | cryptolepine results in increased expression of BAX protein |
increases expression
|
protein |
16120219
|
C024015 | 330 |
BIRC3
AIP1 API2 CIAP2 HAIP1 HIAP1 MALT2 MIHC RNF49 c-IAP2 |
baculoviral IAP repeat containing 3 | cryptolepine results in decreased expression of BIRC3 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 699 |
BUB1
BUB1A BUB1L hBUB1 |
BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) | cryptolepine results in decreased expression of BUB1 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 701 |
BUB1B
BUB1beta BUBR1 Bub1A MAD3L MVA1 SSK1 hBUBR1 |
BUB1 mitotic checkpoint serine/threonine kinase B (EC:2.7.11.1) | cryptolepine results in decreased expression of BUB1B mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 890 |
CCNA2
CCN1 CCNA |
cyclin A2 | cryptolepine results in decreased expression of CCNA2 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 890 |
CCNA2
CCN1 CCNA |
cyclin A2 | cryptolepine results in decreased expression of CCNA2 protein |
decreases expression
|
protein |
16120219
|
C024015 | 891 |
CCNB1
CCNB |
cyclin B1 | cryptolepine results in decreased expression of CCNB1 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 891 |
CCNB1
CCNB |
cyclin B1 | cryptolepine results in decreased expression of CCNB1 protein |
decreases expression
|
protein |
16120219
|
C024015 | 595 |
CCND1
BCL1 D11S287E PRAD1 U21B31 |
cyclin D1 | cryptolepine results in increased expression of CCND1 mRNA |
increases expression
|
mRNA |
16120219
|
C024015 | 995 |
CDC25C
CDC25 PPP1R60 |
cell division cycle 25C (EC:3.1.3.48) | cryptolepine results in decreased expression of CDC25C mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 997 |
CDC34
E2-CDC34 UBC3 UBCH3 UBE2R1 |
cell division cycle 34 (EC:6.3.2.19) | cryptolepine results in decreased expression of CDC34 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 31052 | cryptolepine results in decreased expression of CDC45L mRNA |
decreases expression
|
mRNA |
16120219
|
||
C024015 | 990 |
CDC6
CDC18L HsCDC18 HsCDC6 |
cell division cycle 6 | cryptolepine results in decreased expression of CDC6 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | cryptolepine results in increased expression of CDKN1A mRNA |
increases expression
|
mRNA |
16120219
|
C024015 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | cryptolepine results in increased expression of CDKN1A protein |
increases expression
|
protein |
16120219
|
C024015 | 1033 |
CDKN3
CDI1 CIP2 KAP KAP1 |
cyclin-dependent kinase inhibitor 3 (EC:3.1.3.16 3.1.3.48) | cryptolepine results in decreased expression of CDKN3 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 1063 |
CENPF
CENF PRO1779 hcp-1 |
centromere protein F, 350/400kDa | cryptolepine results in decreased expression of CENPF mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 9518 |
GDF15
GDF-15 MIC-1 MIC1 NAG-1 PLAB PTGFB |
growth differentiation factor 15 | cryptolepine results in increased expression of GDF15 mRNA |
increases expression
|
mRNA |
16120219
|
C024015 | 4171 |
MCM2
BM28 CCNL1 CDCL1 D3S3194 MITOTIN cdc19 |
minichromosome maintenance complex component 2 (EC:3.6.4.12) | cryptolepine results in decreased expression of MCM2 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 4175 |
MCM6
MCG40308 Mis5 P105MCM |
minichromosome maintenance complex component 6 (EC:3.6.4.12) | cryptolepine results in decreased expression of MCM6 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 4176 |
MCM7
CDC47 MCM2 P1.1-MCM3 P1CDC47 P85MCM PNAS146 |
minichromosome maintenance complex component 7 (EC:3.6.4.12) | cryptolepine results in decreased expression of MCM7 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 84515 |
MCM8
C20orf154 dJ967N21.5 |
minichromosome maintenance complex component 8 (EC:3.6.4.12) | cryptolepine results in decreased expression of MCM8 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 4193 |
MDM2
ACTFS HDMX hdm2 |
MDM2 oncogene, E3 ubiquitin protein ligase | cryptolepine results in increased expression of MDM2 mRNA |
increases expression
|
mRNA |
16120219
|
C024015 | 4193 |
MDM2
ACTFS HDMX hdm2 |
MDM2 oncogene, E3 ubiquitin protein ligase | cryptolepine results in increased expression of MDM2 protein |
increases expression
|
protein |
16120219
|
C024015 | 4661 |
MYT1
C20orf36 MTF1 MYTI PLPB1 ZC2HC4A |
myelin transcription factor 1 | cryptolepine results in decreased expression of MYT1 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 4751 |
NEK2
HsPK21 NEK2A NLK1 |
NIMA-related kinase 2 (EC:2.7.11.1) | cryptolepine results in decreased expression of NEK2 mRNA |
decreases expression
|
mRNA |
16120219
|
C024015 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | cryptolepine results in increased activity of TP53 protein |
increases activity
|
protein |
16120219
|
C024015 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | cryptolepine results in increased expression of TP53 protein |
increases expression
|
protein |
16120219
|
C024015 | 7272 |
TTK
CT96 ESK MPH1 MPS1 MPS1L1 PYT |
TTK protein kinase (EC:2.7.12.1) | cryptolepine results in decreased expression of TTK mRNA |
decreases expression
|
mRNA |
16120219
|